Product Information
ONDANSETRON ODT 8 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1686 per EA under NDC 57237007850. Its NADAC has been published 92 times since Jan 1, 2025.
FDA first approved this application on Apr 12, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237007850
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ONDANSETRONApproval Type
Generic (ANDA)
FDA Application
ANDA090469FDA Approved
4/12/2010
TE Code
AB
On Market Since
4/12/2010
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON ODT 8 MG TABLET has been published 92 times since Jan 1, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1686 per EA |
|---|---|
| All-time high | $0.1926 (Sep 10, 2025) |
| All-time low | $0.1616 (Aug 19, 2026) |
| 52-week high | $0.1838 |
| 52-week low | $0.1616 |
| Median price | $0.1752 |
| Average price | $0.1764 |
| Largest weekly change | +6.0% (Mar 19, 2025) |
| Weeks tracked | 92 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON ODT 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON ODT 8 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1686 per EA (NDC 57237007850), effective Sep 30, 2026.
How has the price of ONDANSETRON ODT 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONDANSETRON ODT 8 MG TABLET has held within roughly two percent of its current level. It has been tracked across 92 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for ONDANSETRON ODT 8 MG TABLET?
Since Jan 1, 2025, the NADAC for ONDANSETRON ODT 8 MG TABLET has ranged from a low of $0.1616 (Aug 19, 2026) to a high of $0.1926 (Sep 10, 2025), with a median of $0.1752 per EA.
Are there cheaper alternatives to ONDANSETRON ODT 8 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ONDANSETRON HCL 8 MG TABLET, is $0.0781 per EA — about 54% below ONDANSETRON ODT 8 MG TABLET.
Who manufactures ONDANSETRON ODT 8 MG TABLET?
ONDANSETRON ODT 8 MG TABLET (NDC 57237007850) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.